Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 May 17.
doi: 10.1007/s00405-025-09442-5. Online ahead of print.

Intraoperative fluorescence in solid head and neck cancer: A scoping review

Affiliations
Review

Intraoperative fluorescence in solid head and neck cancer: A scoping review

Brian A Keith et al. Eur Arch Otorhinolaryngol. .

Abstract

Purpose: Obtaining negative margins in primary tumor resection is essential to decreasing recurrence and mortality. Fluorescence imaging may aid in complete tumor removal. As fluorescent agents are still under clinical trial investigation for use in head and neck cancer (HNC), their effectiveness in intraoperative margin assessment (IMA) remains unclear. This scoping review examines the use of fluorescent-guided surgery (FGS) in the treatment of HNC, highlighting significant opportunities in this nascent field.

Methods: PubMed, Scopus, CINAHL, and Cochrane Library were searched from inception through March 22, 2024. This study was conducted under PRISMA-ScR guidelines. Data on study characteristics, fluorescence and imaging techniques, imaging efficacy, and diagnostic accuracy were extracted.

Results: Twenty-seven prospective studies from 2013 to 2024 on intraoperative FGS in HNC, involving 455 patients from six countries, were included. Studies ranged from preclinical to phase II trials, applying various fluorescent techniques, predominantly indocyanine green and IRDye800CW, to enhance surgical precision. Imaging assessments were conducted in-vivo, ex-vivo, or both, using a wide range of devices and taking an additional 0 to 30 min intraoperatively. Quantitative measures like signal-to-background ratio and mean fluorescent intensity suggested variable diagnostic accuracy across studies. FGS shows great potential in improving IMA, although standardization in methodologies and reporting is needed.

Conclusion: This scoping review highlights the potential of intraoperative FGS to enhance treatment accuracy in solid HNC, though variability in diagnostic efficacy and a lack of standardized methodologies persist. Advancements in fluorophore technology and uniform procedural protocols are essential to optimize surgical outcomes and move towards personalized HNC interventions.

Keywords: Fluorescent-guided surgery; Head and neck cancer; Intraoperative imaging; Intraoperative margin assessment.

PubMed Disclaimer

Conflict of interest statement

Declarations. Institutional review board statement: Not applicable. Compliance with ethical standards: As this manuscript is a scoping review analyzing existing published literature, we adhered to ethical principles by ensuring transparency in our methodology, accurately representing the findings of included studies, and avoiding any potential for bias in our interpretation and reporting of results. No ethical approval was required as we are not collecting primary data from human participants. Conflicts of interest: AEK is a speaker for Vioptix Inc and Cooper Surgical; JGN is a consultant for Castle Biosciences, Hologic Inc., CelSci Inc., and Regeneron.

Similar articles

References

    1. Kim KJ, Kim KJ, Choi J, Kim NH, Kim SG (2023) Linear association between radioactive iodine dose and second primary malignancy risk in thyroid cancer. J Natl Cancer Inst 115(6):695–702. https://doi.org/10.1093/jnci/djad040 - DOI - PubMed - PMC
    1. Eldeeb H, Macmillan C, Elwell C, Hammod A (2012) The effect of the surgical margins on the outcome of patients with head and neck squamous cell carcinoma: single institution experience. Cancer Biol Med 9(1):29–33. https://doi.org/10.3969/j.issn.2095-3941.2012.01.005 - DOI - PubMed - PMC
    1. Ravasz LA, Slootweg PJ, Hordijk GJ, Smit F, van der Tweel I (1991) The status of the resection margin as a prognostic factor in the treatment of head and neck carcinoma. J Craniomaxillofac Surg 19(7):314–318. https://doi.org/10.1016/s1010-5182(05)80339-7 - DOI - PubMed
    1. Kurita H, Nakanishi Y, Nishizawa R, Xiao T, Kamata T, Koike T et al (2010) Impact of different surgical margin conditions on local recurrence of oral squamous cell carcinoma. Oral Oncol 46(11):814–817. https://doi.org/10.1016/j.oraloncology.2010.08.014 - DOI - PubMed
    1. Nocon CC, Ajmani GS, Bhayani MK (2018) Association of facility volume with positive margin rate in the surgical treatment of head and neck cancer. JAMA Otolaryngol Head Neck Surg 144(12):1090–1097. https://doi.org/10.1001/jamaoto.2018.2421 - DOI - PubMed - PMC

LinkOut - more resources